Clinical Trial Update: R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty [Phase 1, Phase 2]

View source ↗

Summary

A multicenter phase Ib/II trial evaluating R2-MTX with lenalidomide maintenance for newly diagnosed primary central nervous system lymphoma is in early stages w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• R2-MTX (R2-MTX)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Central Nervous System Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN